Cargando…
Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Editora Ltda.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582984/ http://dx.doi.org/10.1016/j.bjorl.2022.10.003 |
_version_ | 1784812967007617024 |
---|---|
author | De Oliveira Santos, Júlia Gaspar Rimoli, Caroline Fernandes Sparaga, Lucas Demetrio Dedavid, Vittoria Senna Oyama, Letícia Akazaki |
author_facet | De Oliveira Santos, Júlia Gaspar Rimoli, Caroline Fernandes Sparaga, Lucas Demetrio Dedavid, Vittoria Senna Oyama, Letícia Akazaki |
author_sort | De Oliveira Santos, Júlia Gaspar |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9582984 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier Editora Ltda. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95829842022-10-20 Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy De Oliveira Santos, Júlia Gaspar Rimoli, Caroline Fernandes Sparaga, Lucas Demetrio Dedavid, Vittoria Senna Oyama, Letícia Akazaki Braz J Otorhinolaryngol Article Published by Elsevier Editora Ltda. 2022 2022-10-20 /pmc/articles/PMC9582984/ http://dx.doi.org/10.1016/j.bjorl.2022.10.003 Text en Copyright © 2022 Published by Elsevier Editora Ltda. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article De Oliveira Santos, Júlia Gaspar Rimoli, Caroline Fernandes Sparaga, Lucas Demetrio Dedavid, Vittoria Senna Oyama, Letícia Akazaki Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy |
title | Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy |
title_full | Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy |
title_fullStr | Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy |
title_full_unstemmed | Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy |
title_short | Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy |
title_sort | incidence and gravity of covid-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582984/ http://dx.doi.org/10.1016/j.bjorl.2022.10.003 |
work_keys_str_mv | AT deoliveirasantosjuliagaspar incidenceandgravityofcovid19inpatientswithallergicrhinitisundertreatmentwithsublingualimmunotherapy AT rimolicarolinefernandes incidenceandgravityofcovid19inpatientswithallergicrhinitisundertreatmentwithsublingualimmunotherapy AT sparagalucasdemetrio incidenceandgravityofcovid19inpatientswithallergicrhinitisundertreatmentwithsublingualimmunotherapy AT dedavidvittoriasenna incidenceandgravityofcovid19inpatientswithallergicrhinitisundertreatmentwithsublingualimmunotherapy AT oyamaleticiaakazaki incidenceandgravityofcovid19inpatientswithallergicrhinitisundertreatmentwithsublingualimmunotherapy |